Xconomy National

Archives

by in
Entry Author Date Location
Pulmatrix Snags $14M, Embera Adds for $4.5 Addiction Drugs, Daktari Gets $1.2M, & More Boston-Area Life Sciences News Erin Kutz 08/19/11 Boston
Alkermes’ Anti-Addiction Drug, Key to Company Pipeline, Passes Early Test Luke Timmerman 10/13/09 Boston
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.